Inactivated polio vaccine hyperimmunization in adults with HIV disease: a placebo-controlled study.

Preformulation study of highly purified inactivated polio vaccine, serotype 3.

Polio endgame: the global introduction of inactivated polio vaccine.

Development of thermostable lyophilized inactivated polio vaccine.

Inactivated polio vaccine launch in Nepal: a public health milestone.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Alternative delivery of a thermostable inactivated polio vaccine.

Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

Antibody response to inactivated polio vaccine (E-IPV) in children born to HIV positive mothers.

Polio inactivated vaccine costs into routine childhood immunization in Brazil.

Parental acceptance of inactivated polio vaccine in Southeast Nigeria: a qualitative cross-sectional interventional study.

Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.

Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

A national reference for inactivated polio vaccine derived from Sabin strains in Japan.

Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine.

Swedish inactivated polio vaccine: laboratory standardization and clinical experience over a 30-year period.

Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.

Vaccination experiments in cattle with a live and with an inactivated Aujeszky's disease virus vaccine.

Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.

AIDS and the polio vaccine.

Suggest Documents

Preformulation study of highly purified inactivated polio vaccine, serotype 3.

Polio endgame: the global introduction of inactivated polio vaccine.

Development of thermostable lyophilized inactivated polio vaccine.

Inactivated polio vaccine launch in Nepal: a public health milestone.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Alternative delivery of a thermostable inactivated polio vaccine.

Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

Antibody response to inactivated polio vaccine (E-IPV) in children born to HIV positive mothers.

Polio inactivated vaccine costs into routine childhood immunization in Brazil.

Parental acceptance of inactivated polio vaccine in Southeast Nigeria: a qualitative cross-sectional interventional study.

Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.

Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

A national reference for inactivated polio vaccine derived from Sabin strains in Japan.

Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine.

Swedish inactivated polio vaccine: laboratory standardization and clinical experience over a 30-year period.

Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.

Vaccination experiments in cattle with a live and with an inactivated Aujeszky's disease virus vaccine.

Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.

AIDS and the polio vaccine.

Inactivated polio vaccine hyperimmunization in adults with HIV disease: a placebo-controlled study.

Recommend Documents

Follow Us